FY23 Supplement for NRT BIQSFP

23 财年 NRT BIQSFP 补充

• 批准号: 10893173
• 负责人: CHARLES D. BLANKE
• 金额: $ 66.33万
• 依托单位: OREGON HEALTH & SCIENCE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-04-17 至 2025-02-28
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10893173
• 关键词: Biological Markers; Funding; Image; Quality of life; Southwest Oncology Group; anticancer research; programs; research study

This is a supplement application for Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP) funding for the following SWOG Cancer Research studies: S1602

这是生物标记、成像和生活质量研究资助计划的补充申请 (BIQSFP) 资助以下 SWOG 癌症研究：S1602

项目成果

A Festschrift in Honor of Edward M. Messing, MD, FACS.

• DOI: 10.3233/blc-189037
• 发表时间: 2018-10-03
• 期刊: Bladder cancer (Amsterdam, Netherlands)
• 作者: Joseph JV;Brasacchio R;Fung C;Reeder J;Bylund K;Sahasrabudhe D;Yeh SY;Ghazi A;Fultz P;Rubens D;Wu G;Singer E;Schwarz E;Mohile S;Mohler J;Theodorescu D;Lee YF;Okunieff P;McConkey D;Rashid H;Chang C;Fradet Y;Guru K;Kukreja J;Sufrin G;Lotan Y;Bailey H;Noyes K;Schwartz S;Rideout K;Bratslavsky G;Campbell SC;Derweesh I;Abrahamsson PA;Soloway M;Gomella L;Golijanin D;Svatek R;Frye T;Lerner S;Palapattu G;Wilding G;Droller M;Trump D
• 通讯作者: Trump D

Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe.

• DOI: 10.1016/j.cllc.2016.06.007
• 发表时间: 2017-01
• 期刊: Clinical lung cancer
• 影响因子: 3.6
• 作者: Salahudeen AA;Patel MI;Baas P;Curran WJ;Bradley JD;Gandara DR;Goss GD;Mok TS;Ramalingam SS;Vokes EE;Malik SM;Wakelee HA
• 通讯作者: Wakelee HA

Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of Immunotherapy.

胸部恶性肿瘤国际合作小组研究的最新进展：免疫疗法的出现。

• DOI: 10.1016/j.cllc.2018.03.004
• 发表时间: 2018
• 期刊: Clinical lung cancer
• 影响因子: 3.6
• 作者: Shukla,NavikaD;Salahudeen,AmeenA;Taylor,GregoryA;Ramalingam,SureshS;Vokes,EverettE;Goss,GlenwoodD;Decker,RoyH;Kelly,Karen;Scagliotti,GiorgioV;Mok,TonyS;Wakelee,HeatherA
• 通讯作者: Wakelee,HeatherA

Checklist for Improving Patient Communication on Bladder Preservation Options: The Patient Advocate Perspective.

改善患者关于保留膀胱选项的沟通的清单：患者倡导者的观点。

• DOI: 10.1016/j.clon.2022.08.023
• 发表时间: 2022
• 期刊: Clinical oncology (Royal College of Radiologists (Great Britain))
• 作者: Bangs,R;Quale,DZ;Reed,T
• 通讯作者: Reed,T

Critical insights into the evolving drug-approval process in China.

对中国不断发展的药品审批流程的批判性见解。

• DOI: 10.1002/cncr.35186
• 发表时间: 2024
• 期刊: Cancer
• 影响因子: 6.2
• 作者: Nikanjam,Mina;Kurzrock,Razelle
• 通讯作者: Kurzrock,Razelle